Status:
COMPLETED
Etoricoxib as a Pre-emptive Analgesic in Therapeutic Arthroscopy
Lead Sponsor:
Marienkrankenhaus Soest
Conditions:
Pain
Eligibility:
All Genders
19-70 years
Brief Summary
The aim of this study is to demonstrate that compared to placebo the preoperative administration of a single dose of 120 mg etoricoxib can provide adequate pain relief in the postoperative phase while...
Detailed Description
Depending on the pain intensity, various analgesics are used in the prevention of surgical wound pain. For severe pain, opioids like piritramide and morphine are used. These can be given at fixed inte...
Eligibility Criteria
Inclusion
- Knee arthroscopy
Exclusion
- Opiate addiction
- Pregnancy or breast-feeding
- Known hypersensitivity to the active substance or to any of the excipients of the film tablet
- Active peptic ulcer or active gastrointestinal bleeding, inflammatory bowel disease, severe hepatic dysfunction (serum albumin \<25 g/l or Child-Pugh score ≥10).
- Further exclusion criteria are congestive heart failure (NYHA II-IV), hypertension with not adequately controlled blood pressure, established ischemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00738608
Start Date
June 1 2006
End Date
September 1 2009
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marienkrankenhaus
Soest, Germany, 59494